Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;29:105-110

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fontana, F.
Right arrow Articles by Grossi, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fontana, F.
Right arrow Articles by Grossi, G.

(Hypertension. 1997;29:105.)
© 1997 American Heart Association, Inc.


Research Articles (Issue 1, Part 1)

Pressor Effects of Endogenous Opioid System During Acute Episodes of Blood Pressure Increases in Hypertensive Patients

Fiorella Fontana; Pasquale Bernardi; Sante Spampinato; Stefano Boschi; Rosaria De Iasio; Gabriele Grossi

Istituto di Patologia Speciale Medica e Metodologia Clinica, Ospedale S Orsola (F.F., P.B.); Dipartimento di Farmacologia (S.S.); Servizio di Farmacologia Clinica, Ospedale S Orsola (S.B., R. De I.); and Laboratorio Centralizzato, Ospedale S Orsola (G.G.), Bologna, Italy.

To investigate the involvement of endogenous opioids in acute increases in blood pressure and their functional relationship with atrial natriuretic factor and endothelin-1, we assessed plasma levels of ß-endorphin, met-enkephalin, dynorphin B, catecholamines, atrial natriuretic factor, and endothelin-1 before and after administration of the opioid antagonist naloxone hydrochloride (8 mg IV) in 28 hypertensive patients with a stress-induced acute increase in blood pressure. Ten patients with established mild or moderate essential hypertension and 10 normotensive subjects served as control groups. Opioids, atrial natriuretic factor, and endothelin-1 were radioimmunoassayed after chromatographic preextraction; catecholamines were determined by high-performance liquid chromatography with electrochemical detection. Patients with an acute increase in blood pressure (systolic, 203.2±2.2 mm Hg; diastolic, 108.4±1.3) had plasma opioid, catecholamine, and atrial natriuretic factor levels significantly (P<.01) higher than hypertensive control patients (systolic pressure, 176.4±1.0 mm Hg; diastolic, 100.0±1.4), who had a hormonal pattern similar to that of normotensive subjects (systolic pressure, 123.2±1.5 mm Hg; diastolic, 75.0±2.0). Endothelin-1 did not differ in any group. In patients with an acute increase in blood pressure, naloxone significantly (P<.01) reduced blood pressure, heart rate, opioids, catecholamines, and atrial natriuretic factor 10 minutes after administration. Naloxone effects on blood pressure, heart rate, opioids, and catecholamines wore off within 20 minutes. In control groups, naloxone failed to modify any of the considered parameters. Our findings suggest that pressor effects of opioid peptides mediated by the autonomic nervous system during stress-induced acute episodes of blood pressure increase in hypertensive patients.


Key Words: blood pressure • catecholamines • atrial natriuretic factor • endothelin-1 • naloxone




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
D. Cozzolino, F. C. Sasso, D. Cataldo, D. Gruosso, A. Giammarco, A. Cavalli, C. Di Maggio, G. Renzo, T. Salvatore, D. Giugliano, et al.
Acute Pressor and Hormonal Effects of {beta}-Endorphin at High Doses in Healthy and Hypertensive Subjects: Role of Opioid Receptor Agonism
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5167 - 5174.
[Abstract] [Full Text] [PDF]